胃癌CT参数与PD-L1表达状态的相关性
回顾性纳入67例胃腺癌患者,治疗前接受腹部CT三期增强扫描及PD-L1免疫组化检测,按CPS≥5分为阳性组、CPS<5分为阴性组。阳性组动脉期强化分数(AEF)显著高于阴性组,AEF评估PD-L1高表达的AUC为0.724,联合参数AUC达0.825、敏感度75.00%、特异度81.40%。作者认为AEF可能有助于评估PD-L1高表达并筛选适合免疫治疗的患者。
要点
- 动脉期强化分数(AEF)在PD-L1阳性组(CPS≥5)显著高于阴性组(CPS<5)。
- AEF评估PD-L1表达的AUC为0.724(95%CI 0.602-0.826)。
- 联合参数诊断效能最佳,AUC 0.825(95%CI 0.716-0.933),敏感度75.00%、特异度81.40%。
核心结论
- 胃癌CT影像特征与PD-L1表达状态存在相关性,AEF可能有助于评估PD-L1高表达并筛选适合免疫治疗的患者。
研究设计与样本
- 回顾性研究,纳入67例经病理确诊的胃腺癌患者(女17例、男50例,平均年龄59.55±10.22岁),治疗前均行腹部CT三期增强扫描及PD-L1免疫组化检测,按CPS≥5为阳性组、CPS<5为阴性组。
关键影像表现/征象
- 总体分期在PD-L1阳性组与阴性组之间差异有统计学意义(p<0.05)。
- 最大淋巴结短径>1 cm的概率在两组之间差异有统计学意义(p<0.05)。
- 病灶强化峰值出现在动脉期的概率在两组之间差异有统计学意义(p<0.05)。
- 动脉期强化分数(AEF)在阳性组显著高于阴性组(p<0.05)。
诊断标准与关键数值
- PD-L1表达状态以CPS≥5为阳性、CPS<5为阴性。
- AEF评估PD-L1表达的AUC为0.724(95%CI 0.602-0.826)。
- 联合参数诊断效能最佳,AUC为0.825(95%CI 0.716-0.933),敏感度75.00%,特异度81.40%。
临床应用与阅片要点
- 作者认为AEF可能有助于评估胃癌PD-L1高表达并筛选适合免疫治疗的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to explore the correlation between routine computed tomography (CT) imaging features and programmed cell death ligand-1(PD-L1) expression status in gastric cancer and evaluate the predictive value of imaging parameters for this immunotherapy biomarker.
MATERIALS AND METHODS: Patients with gastric adenocarcinoma who underwent abdominal CT three-stage enhanced scan and PD-L1 immunohistochemical testing before treatment were retrospectively examined. All diagnoses were confirmed through pathology. According to the expression status of PD-L1, they were divided into the positive (CPS ≥ 5) or negative group (CPS < 5). Baseline CT imaging features were collected. Diagnostic performances of the different variables were evaluated using receiver operating characteristic (ROC) curve.
RESULTS: In total, 67 patients (17 women and 50 men; mean age: 59.55 ± 10.22 years) with gastric adenocarcinoma were included in the study. The overall stages, probability of maximum lymph node short diameter > 1 cm and peak of lesion enhancement occurring in the arterial phase were statistically significant between the two groups (p < 0.05). Moreover, the arterial enhancement fraction (AEF) was significantly higher in the positive group than that in the negative group (p < 0.05), and ROC curve analysis showed that the AEF exhibited a high evaluation efficacy (area under the curve [AUC] = 0.724 [95% confidence interval (CI): 0.602-0.826]). The combined parameters had the best diagnostic efficacy (AUC = 0.825 [95%CI: 0.716-0.933]), sensitivity (75.00%), and specificity (81.40%).
CONCLUSIONS: These findings confirm a correlation between CT imaging features and PD-L1 expression status in gastric cancer, and AEF may help evaluate high PD-L1 expression and select patients suitable for immunotherapy.
引用
- Xu M, Ren T, Deng J, et al. Correlation of CT parameters and PD-L1 expression status in gastric cancer. Abdom Radiol (NY). 2024. PMID: 38436699. doi:10.1007/s00261-024-04200-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。